Arcturus Therapeutics Holdings Inc. / Fundamentals
Income statement
- Net revenue
€100.81M - Cost of goods sold
-€2.45M - Gross profit
€78.28M - SG&A expenses
€40.59M - R&D expenses
€126.46M - EBITDA
-€47.46M - D&A
€2.17M - EBIT
-€62.27M - Interest expenses
€0.00 - EBT
-€51.81M - Tax expenses
-€186.19K - Net income
-€51.62M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€38.02M - Changes in working capital
€28.67M - Operating cash flow
-€56.16M - Capex
-€483.35K - Other investing cash flow
-€669.54K - Net investing cash flow
-€190.18K - Total cash dividends paid
€0.00 - Issuance of common stock
-€3.32M - Debt repayment
€0.00 - Other financing cash flow
€1.11M - Net financing cash flow
€1.11M - Foreign exchange effects
€0.00 - Net change in cash
-€54.79M - Cash at end of period
€217.38M - Free cash flow
-€56.65M
Balance sheet
- Cash and cash equivalents
€168.57M - Cash and short-term investments
€168.57M - Total receivables
€14.76M - Inventory
€0.00 - Other current assets
€52.19M - Total current assets
€235.52M - Property, plant & equipment
€28.21M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€1.62M - Other non-current assets
€0.00 - Total non-current assets
€29.83M - Total assets
€265.35M - Accounts payable
€9.11M - Short-term debt
€0.00 - Other current liabilities
€21.13M - Total current liabilities
€39.91M - Long-term debt
€19.68M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€27.20M - Total liabilities
€67.11M - Common stock
€23.17K - Retained earnings
-€405.03M - Other equity
€0.00 - Total equity
€198.24M - Total liabilities and shareholders' equity
€265.35M
Company information
- Market capitalization
€308.36M - Employees
174 - Enterprise Value
€159.42M
Company ratios
- Gross margin
-
77.6% Much worse than peer group: 2,893,824,803,937,149,200.0% - EBITDA margin
-
-47.1% Much worse than peer group: 4,428,103,866,306,066,000.0% - EBIT margin
-
-61.8% Much worse than peer group: 4,259,877,855,383,425,000.0% - EBT margin
-
-51.4% Much worse than peer group: 5,035,693,799,738,693,600.0% - Net margin
-
-51.2% Much worse than peer group: 5,035,693,799,738,693,600.0% - ROE
-
-26.0% Much better than peer group: -55.7% - ROA
-
-19.5% Much better than peer group: -43.7% - Asset turnover
-
38.0% Much better than peer group: 8.8% - FCF margin
-
-55.2% Much worse than peer group: 3,763,876,235,786,307,000.0% - FCF yield
-18.1% - Efficiency ratio
147.1% - Net sales per employee
-
€579.39K - Net income per employee
-
-€296.67K